
.jpg)
Download My CV: here
Dr. Conrad B. Quintyn is professor of biological anthropology at Bloomsburg University, Bloomsburg, PA.17815, U.S.A. He was educated at Baylor University (B.A., 1991), University of Michigan (M.A., 1993), and University of Michigan (Ph.D., 1999). From 2000 to 2001, he taught at Iowa State University. From 2001 to 2002, he worked as a biological anthropologist for the Joint POW/MIA Accounting Command [JPAC] Laboratory (currently called Defense POW/MIA Accounting Agency [DPAA]) located on Hickam Air Force Base, Honolulu, Hawaii. There he conducted search, recovery, and identification of the remains of U.S. soldiers listed as missing-in-action from World War II and the Vietnam War. Occasionally, he assists the Pennsylvania State Police in the recovery and identification of human remains His interests include worldwide postcranial variation (i.e., osteometric analysis of skeletal collections in various domestic and international museums), evolutionary biology, the problem of species, evolution of human diseases, and forensic anthropology. Genetic engineering and medical genetics have been an interest (and concern) of Dr. Quintyn since his postgraduate studies in biological anthropology. As a student of evolutionary biology, he praises the scientific breakthroughs in biotechnology leading to cures for some diseases. But, he worries about the impact of genetic engineering on future evolutionary change and the Anthropocene the period of greatest human impact on Earth’s biotic and abiotic resources. In his research, Dr. Quintyn has collected human skeletal data from the Peabody Museum of Archaeology & Ethnology, Harvard University, Cambridge, MA; the Natural History Museum, London, UK; the Museum National D’ Histoire Naturelle, Paris, France; and the William S. Webb Museum of Anthropology, University of Kentucky, Lexington, KY. He isthe editor of an academic text titled Readings in Evolutionary Theory, Genetics, and the Origins of Modern Morphology (San Diego: Cognella Academic Publishing) published in summer 2021. Dr. Quintyn was born in London, U.K. and he immigrated to the United States in 1978. Two years after graduating high school, Dr. Quintyn enlisted in the U.S. Navy for active duty in January 1983 and was honorably discharged in January 1987. Subsequently, he served two years inactive reserve while attending university.
The Biotechnology book and my general philosophy:
The impetus for writing Biotechnology came after reading Daniel J. Kevles’s book In the Name of Eugenics: Genetics and the Uses of Human Heredity, first published by Harvard University Press in 1985. Although all the chapters of Kevles’s book were quite stimulating, Chapter 17, “A New Eugenics,” really piqued my interest. In this chapter, Kevles presented a short history of the research that led to genetic engineering (such as clon-ing amphibians, in vitro fertilization, and recombinant DNA) and the determination of geneticists to “reduce the incidence of genetic disease in the population.” In addition, Kevles made it clear that cloning, germinal choice, and sperm banks echoes of the “old” eugenics were inter-twined with genetic engineering. Outside of Kevles’s book, genetic engineering and medical genetics have been an interest (and concern) of mine since my postgraduate studies in biological anthropology. As a student of evolutionary biology, I praise the scientific breakthroughs in biotechnology leading to cures for some diseases. But, I worry about the impact of genetic engineering on future evolutionary change and the Anthropocene the period of greatest human impact on Earth’s biotic and abiotic resources. Humans’ impact on the natural environment over the past 12,000 years through the agricultural revolution, civilization, the Industrial Revolution, and the atomic revolution has been so great that the negative effects are still apparent today in terms of infectious and noninfectious diseases (such as respiratory diseases and cancers) and global warming. The long-term evolutionary impact on human biology and, as far as global warming is concerned, the evolutionary impact on other organisms remains unknown.
Returning to genetic engineering, biotechnology is advancing globally at an incredible rate, and as with computer technology and the inter-net, there is no strong regulation. Or, put another way, the current regulations are being stretched beyond their limits. For example, an important question posed today is whether genome editing should be regulated as a technology or a drug. In the 1970s, the important question was whether recombinant retroviruses, with their propensity for mutagenesis, should be used in gene therapy. This concern prompted the US National Academy of Sciences and National Institutes of Health (NIH) to ask concerned scientists to organize a meeting, leading to the Asilomar Conference on Recombinant DNA, held in February 1975 at the Asilomar Conference Center in Pacific Grove, California, which proposed guide-lines to ensure the safe use of recombinant DNA. Forty years later in January 2015, another Asilomar-like conference was held in Napa, California, to discuss the path forward for genomic engineering. The questions raised at this conference surrounding the use of gene editing tools required a global discussion that resulted in an international summit on human gene editing, held in Washington, DC, in December of the same year. Three years later in November 2018, a second international conference held in Hong Kong addressed the claims of a Chinese scientist who had supposedly used genome editing to make genetic alterations in early embryos and implant them. Moreover, scientists are still operating in the Wild West, with mostly good intentions mixed in with hubris, lucrative patents for their host institutions, fame, and Nobel Prizes. Infused with these potent stimuli, they propel themselves blindly ahead with no consideration of the consequences. Mary Shelley’s Frankenstein and H. G. Wells’s The Island of Dr. Moreau are just two prominent fictional tales written to reach a wider audience and emphasize philosophical themes such as the violation of nature, cruelty, moral responsibility, and respecting the boundaries of humankind in the context of experiments with animal-human hybrids and animal chimeras. Taking the baton from Kevles, I used his Chapter 17 as a foundation on which to build a discussion of bioengineering in the 21st century.
My motivation for writing Biotechnology is rooted in several important concerns within biotechnology. For instance, although the mice in which the gene for the p53 tumor suppressor was inactivated were born normal, they exhibited an increased incidence of tumors during growth and development. This problem highlights the complexity of gene function and the varied reactions when one gene is inactivated: genes rarely work in isolation. In another example, the first DNA vaccine spliced an influenza gene encoding a nucleoprotein into a plasmid, which was then injected into mice, where it caused an immune response to influenza. Viruses have an RNA genome replicated by a viral RNA polymerase that lacks proofreading ability. Over time, mutations accumulate in surface proteins resulting in different strains of the virus. Thus, the DNA vaccine could create a new strain of virus or an allergic reaction. In a more alarming example, an interrupting RNA vector was used to suppress the mutant gene responsible for the X-linked form of severe combined immunodeficiency disease (X-SCID) and replace it with a working copy. During clinical trials, several patients developed the same rare type of leukemia. The engineered retrovirus used to introduce the X-SCID gene activated a proto-oncogene in these patients. Although some patients survived long after this gene therapy, the critical factors that biologists must consider when performing genetic engineering are unintended effects of genes, immunogenic proper-ties of viral vectors used, pleiotropic effects (the individual’s genetic background, population history, physiology, diet, and environment), and their own tunnel vision in treating genes as separate from environmental context. In another worrying example, to produce plants resistant to insects, a gene for Bt toxin was inserted into crop plants, which caused insects to die when they ingested the plants. Enzymes within the insects’ systems convert Bt toxin into an insect-specific toxin. These enzymes have not been found in other organisms yet; consequently, Bt toxin is harmless to them. But for how long will this be true? Finally, what are the long-term effects of genetically modified crops on human health? Will introduced genes in crops spread into wild relatives, impacting biodiversity? These questions are unanswered right now, and I believe this is a major problem.
Genetic engineering, particularly genetic editing, has burst upon the scene, and the accuracy of the techniques involved improves every year. The US National Academies of Sciences, Engineering, and Medicine stated that the science of genome editing has advanced rapidly since 2015 and powerful, precise editing tools are being employed to treat diseases. But, there are two major concerns on governance of human genome editing and use of genome editing on the egg and/or sperm resulting in heritable alterations. Clustered regularly interspaced short palindromic repeats/Cas9 (CRISPR/Cas9) is a technique based on the way that bacteria immunize themselves (and future progeny) against viral infection. Cas9 (which stands for CRISPR-associated nuclease) is an enzyme that cuts DNA of essentially any cell type. Since CRISPR/Cas9 is not tightly restricted research (as in, for example, the gain-of-function H5N1 avian influenza studies commonly known as bird flu) and is available to researchers globally, it could be used to edit the genomes of human repro-ductive cells or human embryos, resulting in designer babies carrying heritable, CRISPR/Cas9-introduced genetic changes.
The genie is out of the bottle, so to speak; the technology is available. Some of these concerns prompted biochemist Jennifer Doudna, one of the creators of CRISPR/Cas9, to write, “With our mastery over the code of life comes a level of responsibility for which we, as individuals and as a species, are woefully unprepared.”1 Generally, I agree with Doudna’s statement. However, I take issue with the suggestion that bioengineers have “mastery over the code of life.” The complexity of life and its inter-action with the environment makes real mastery of life impossible; there-fore, the beginning of Doudna’s statement is more hyperbole than hubris.
The goal of scientific advances in general, and those in biotechnology in particular, is to make life better for humankind (e.g., repairing damaged cells and tissues, curing diseases, and improving and protecting crop plants from insects and adverse climate). These goals indicate that scientists in the “trenches” doing the hard work are honorable men and women serving humankind. Of course, there will always be the dangers of dual use, gene drives, and countries with limited laws to regulate their scientists (to prevent, for example, risky gain-of-function virus studies that could spark deadly pandemics through mishandling and faulty containment). And do not forget that market forces with the indirect help of so-called transhumanists who advocate the use of technology to make humans better will seek large profits by exploiting our human desire to be mentally and physically fitter than we already are. Nevertheless, five key questions must be answered:
How and where should the line be drawn for the Promethean task of genetic engineering? In other words, how should public safety and scientific advancement be balanced? Or are these entities two sides of the same coin in other words, a false dichotomy?
2. How should therapy be differentiated from elective genetic enhancement within the social context?
3. What are the microevolutionary (short-term) and macroevolutionary (long-term) effects of genetic engineering on the genome of biological organisms?
4. Do the risks of genome alterations in biological organisms outweigh the benefits, in that inherited deleterious mutations will occur gradually over time, resulting in species extinctions?
5. If only the rich have access to genetic enhancements, will this lead to competition within that social group that further isolates them from the majority of people?
List of Published Books:
Book title: (2023) Biotechnology: Scientific Advancement versus Public Safety. http://www.worldscientific.com/worldscibooks/10.1142/12916
Book title: (2022) Readings in Evolutionary Theory, Genetics, and the Origins of Modern Human Morphology. Edited by Conrad B. Quintyn
Book title: (2010) The Existence or Non-existence of Race?: Forensic Anthropology, Population Admixture, and the Future of Racial Classification in the U.S.
http://www.teneopress.com/teneopress.cfm?template=4&bid=407
Social Media Profiles:
ResearchGate: https://www.researchgate.net/profile/Conrad-Quintyn?ev=hdr_xprf
LinkedIn: https://www.linkedin.com/in/conrad-quintyn-639361387/
Commonwealth University—Bloomsburg webpage: https://www.commonwealthu.edu/people-directory/conrad-quintyn
Facebook: https://www.facebook.com/conrad.quintyn
Contact Email:
cquintyn@commonwealthu.edu OR cbquintyn@hotmail.com
Reviews and Endorsements:
Book reviews (or overview of books) can be found on the purchase links/publisher sites and book covers (i.e., shown on the Biotechnology…cover).
Dr. Conrad B. Quintyn
Dr. Conrad B. Quintyn is a distinguished academic author and researcher whose work bridges the gap between biological anthropology and the ethical implications of scientific advancement. His scholarship explores the intricate relationship between human biology and society, focusing on biotechnology, genetics, and the future of human morphology. With a career dedicated to rigorous academic inquiry, Dr. Quintyn has published extensively on topics ranging from forensic anthropology to the philosophical foundations of evolutionary theory. His approach is characterized by a commitment to intellectual authority and a deep respect for the complexities of human evolution, making his research a vital resource for students, researchers, and academic professionals worldwide.
Academic Focus
Biotechnology
Exploring the intersection of genetic engineering and public safety, focusing on the ethical implications of CRISPR and modern biotechnological advancements.
Anthropology
Investigating the biological foundations of human identity, forensic anthropology, and the complex debates surrounding racial classification in the modern era.
Evolution
Analyzing the origins of modern human morphology through the lens of evolutionary theory, population genetics, and primate behavioral studies.
Scholarly Contributions
Dr. Conrad B. Quintyn’s research explores the intricate intersection of biotechnology, human evolution, and forensic anthropology. His publications provide a rigorous, evidence-based examination of scientific advancement and its societal implications, bridging the gap between complex biological theory and real-world human identity.